Document is current
Any future updates will be listed below
-
Authors
Rojas, Asheebo
Amaradhi, Radhika
Banik, Avijit
Jiang, Chunxiang
Abreu-Melon, JuanMartin
Wang, Sarah
Dingledine, Raymond
Ganesh, Thota
-
Funding
Funding for this research was provided by:
National Institute on Aging (AG052460)
National Institute of Neurological Disorders and Stroke (NS101167, NS097776, NS112308)
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: A Novel Second-Generation EP2 Receptor Antagonist Reduces Neuroinflammation and Gliosis After Status Epilepticus in Rats
Journal Title: Neurotherapeutics
CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-020-00969-5
Content Type: article
Copyright: Copyright © 2021 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.
